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Abstract
There is great interest in substituting animal work with in vitro experimentation in human health risk assessment;
however, there are only few comparisons of in vitro and in vivo biological responses to engineered nanomaterials.
We used high-content genomics tools to compare in vivo pulmonary responses of multiwalled carbon nanotubes
(MWCNT) to those in vitro in cultured lung epithelial cells (FE1) at the global transcriptomic level. Primary size,
surface area and other properties of MWCNT- XNRI -7 (Mitsui7) were characterized using DLS, SEM and TEM. Mice
were exposed via a single intratracheal instillation to 18, 54, or 162 μg of Mitsui7/mouse. FE1 cells were incubated
with 12.5, 25 and 100 μg/ml of Mitsui7. Tissue and cell samples were collected at 24 hours post-exposure. DNA
microarrays were employed to establish mechanistic differences and similarities between the two models. Microarray
results were confirmed using gene-specific RT-qPCR. Bronchoalveolar lavage (BAL) fluid was assessed for
indications of inflammation in vivo. A strong dose-dependent activation of acute phase and inflammation response
was observed in mouse lungs reflective mainly of an inflammatory response as observed in BAL. In vitro, a wide
variety of core cellular functions were affected including transcription, cell cycle, and cellular growth and proliferation.
Oxidative stress, fibrosis and inflammation processes were altered in both models. Although there were similarities
observed between the two models at the pathway-level, the specific genes altered under these pathways were
different, suggesting that the underlying mechanisms of responses are different in cells in culture and the lung tissue.
Our results suggest that careful consideration should be given in selecting relevant endpoints when substituting
animal with in vitro testing.
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Introduction
It is anticipated that the widespread use of engineered
nanomaterials (ENM) in consumer products will lead to
increased human exposure as a result of environmental
contamination and using consumer goods containing ENM.
Because of their nano size and distinct physico-chemical
properties, exposure to ENM is suggested to cause different
toxic responses than exposure to their larger counterparts.
However, hazard characterization and human health risk
assessment of ENM is hampered by a lack of validated
toxicological methods for assessing ENM, and a lack of
appropriate dose metrics and methodologies for sample
preparation (reviewed in 1). Indeed, it has been estimated that
it would require billions of dollars and close to 50 years to
employ traditional toxicological methods to assess the ENM
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currently on the market [2]. Thus, there is an urgent need for
the development of rapid alternative testing strategies.
Many efforts have been made to develop inexpensive, rapid,
and simple in vitro screening assays to assess and predict
ENM-induced toxicity. Although limited in number, studies
comparing in vitro and in vivo biological responses following
ENM exposure have found generally poor concordance
between the two test systems [3,4]; these experiments
question the relevance of in vitro findings to in vivo health
effects for ENM. For example, Seagrave et al. [3] found that
diesel exhaust particle extracts were less toxic in in vitro tests
in rat alveolar macrophages, but more toxic in rat lungs [3].
Sayes et al. [4] reported little correlation in the toxicological
properties of five different types of fine- and nano-particles
following in vivo instillation of rats compared to in vitro
exposures using three different cell culture models (rat lung
epithelial cells, rat primary alveolar macrophages and co-
culture of lung epithelial and primary alveolar macrophages)
[4]. Broadly different responses were also reported for in vivo
compared to in vitro exposures to fine zinc oxide particles, and
to fullerene, carbon nanotubes (CNT), gold and silver
nanoparticles [5,6], reviewed in 7,8. Differences in in vitro and
in vivo responses may be expected because in vivo studies
evaluate toxicity in whole organisms or organs with
complicated interplay between multiple cell types, whereas in
vitro studies primarily focus on understanding the response of a
single cell type isolated from a specific organ. It should also be
noted that the comparisons described above are limited to a
small set of biological endpoints that include inflammatory
markers, oxidative stress, cytotoxicity and markers of tissue
damage.
In contrast to the studies described above, there appears to
be agreement between the in vitro and in vivo models for the
evaluation of genotoxic potential of nanomaterials (reviewed in
9). These findings suggest that careful selection of cell types,
toxicity endpoints and knowledge of the related tissue
physiology is important to derive meaningful comparisons.
Moreover, the data demonstrate that the biological responses
and pathologies associated with exposure to ENM are
complex, and involve perturbations of several pathways and
functions. The use of systems biology approaches to gain
knowledge of the intricate relationship between the pathways
leading to toxicity in these systems is required not only to
understand the underlying etiologies of ENM-induced effects,
but also to validate the relevance of in vitro results, undertaken
to predict in vivo risk.
CNTs are cylindrical carbon allotropes. Their nano size, high
aspect ratio (length/width), and fibre shape render their
properties asbestos-like resulting in potentially higher toxicity
than larger sized particles [10-12]. CNTs are categorized as
either single-walled (SWCNT, single sheet of graphene) or
multi-walled (MWCNT, multiple sheets of graphene) based on
their wall numbers. MWCNT, which are the focus of the current
study, are widely used in many industrial and biomedical
applications [11,13,14] and consequently, occupational
exposure to MWCNT has increased. In vivo animal exposure
models clearly demonstrate that inhalation or instillation of
MWCNT into the lungs induces inflammation, persistent
interstitial fibrosis, and granuloma formation in rodents [15-20].
Studies on mice given intraperitoneal injections of MWCNT of
different shapes and lengths into the mesothelial lining of the
peritoneal cavity show that length and diameter are important
for the infiltration of inflammatory cells into the lungs and lung
fluid [21,22] inciting inflammation. MWCNT are biopersistent,
cause chronic tissue injury and at least in some situations, are
carcinogenic. Indeed, it was recently shown that p53
heterozygous mice or rats given intraperitoneal or intrascrotal
injection of MWCNT develop mesotheliomas in a dose-
dependent manner [23,24] (NIOSH bulletin). For these
reasons, we believe that at the doses tested, MWCNT should
be considered as causing serious health effects and possibly
being carcinogenic.
The primary objective of the present study was to delineate
the mechanisms underlying the biological responses of an in
vitro lung epithelial monolayer cell culture model, relevant to
the in vivo lung tissue response, following exposure to MWCNT
to shed light on the utility of in vitro models to predict adversity
in vivo. MWCNT- XNRI -7 (Mitsui7) was used as a model
MWCNT particle. To accomplish our objective, we
characterized global transcriptional responses in the lungs of
C57BL/6 mice exposed to Mitsui7 and compared them to
transcriptional profiles from mouse lung epithelial cells exposed
to Mitsui7 in culture. C57BL/6 mice were used to study in vivo
effects because all of our previous and ongoing in vivo studies
on different particle types have been conducted on this strain.
Therefore, the results of this study will also enable consistent
and systematic comparisons of biological responses across
particle types. The mouse lung epithelial cell line FE1 was used
to investigate in vitro responses to Mitsui7. FE1 is a
spontaneously immortalized lung epithelial cell line derived
from a normal healthy MutaTMMouse. This cell line retains key
endogenous metabolic capacity and p53 signalling, and
presents both a type I and type II alveolar phenotype. Because
the Muta™Mouse model contains a lacZ mutation reporter
transgene, this cell line also enables an assessment of the
mutagenic effects of nanomaterials and has been extensively
used in our laboratory for studying the genotoxicity of
chemicals and nanomaterials [25-31].
In vitro doses were chosen based on their relevance to in
vivo lung burden and also to reflect the doses reported in the
literature. DNA microarrays were used to examine the
responsive biological pathways and functions altered in FE1
cells incubated in the presence of 12.5, 25, 100 µg/ml Mitsui7
relative to lung tissues exposed via intratracheal instillation to
18, 54, 162 µg/mouse Mitsui7. Samples were collected at 24
hours post-exposure. Statistical and systems biology tools
were employed to provide a global foot-print of Mitsui7-
responsive pulmonary transcriptome in the two widely studied
models. In vivo characterization of lung inflammation and
validation of microarray results by RT-qPCR were further used
to support the conclusions derived.
In Vitro-In Vivo Transcriptomic Responses to MWCNT
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Materials and Methods
Material characteristics
The MWCNT used in this study is a MWCNT- XNRI-7; lot
05072001K28, Hadoga Chemical industry (formerly known as
Mitsui). In this study it will be referred to as Mitsui7. Chemical
composition and length of the same [18] and a different batch
[23] have been published previously and results are
summarized in Table 1. In brief, the average particle length of
Mitsui7, as reported by the manufacturer, is 3-5 μm. One gram
of Mitsui7 corresponds to 3.55 x 1011 particles and consists of
particles with an average width of ca. 100 nm. Transmission
Electron Microscopy (TEM) revealed that the median length of
Mitsui7 is 3.86 μm with 27.5% of Mitsui7 particles having
lengths longer than 5 μm [23]. The numbers of walls vary from
20 to 50 [18]. Major impurities as determined by the collision
type Inductively Coupled Plasma Mass Spectrometry,
Combustion Ion Chromatography and trace metal analysis
included Fe: (0.3%), Na: 0.4% S: ca. 470 ppm and Cl: ca. 20
ppm (18) [23].
Characterization of Mitsui7 in dispersion medium
Scanning Electron Microscopy.  Size and the level of
agglomeration was evaluated by Scanning Electron Microscopy
(SEM) using a Zeiss Ultra 55 (Carl Zeiss Microscopy GmbH,
Germany) SEM equipped with a field emission electron source.
High vacuum conditions were applied and a secondary electron
detector was used for image acquisition. Samples were
prepared on a carbon tape surface and coated with a
conductive layer of Au with approximately 20 nm thickness.
Mitsui7 as dry pristine powders and dispersed in the exposure
media, was analyzed by SEM.
Preparation of Mitsui7 exposure stock
For in vitro exposures.   Immediately before the treatment,
Mitsui7 suspensions were prepared as follows. A total of 8.9
mg of Mitsui7 was suspended in 2.6 ml of cell culture media to
a total stock concentration of 3.4 mg/ml. Particle suspensions
were prepared by sonication of Mitsui7 stock concentrations
using a S-450D sonifier (Branson Ultrasonics Corp., Danbury,
CT, USA) equipped with a disruptor horn (Model Number:
Table 1. Known characteristics of MWCNT-Mitsui-7.
References Dispersion Tube length
Tube Width ±
SD Impurities
Mitsui, Tokyo,
Japan ND
Segments; 3-5
μm long ND ND
Tagaki et al.
2008
5% Triton
X-100
27.5% longer
than 5 μm 100 nm
Fe: 0.35% S:
0.047%
Porter et al.
2010
PBS and
dispersion
media
Median length:
3.86 μm 49±13.4 nm
Fe: 0.32% Na:
0.41%
ND: Not Determined
doi: 10.1371/journal.pone.0080452.t001
101-147-037) for a total of 4 minutes at amplitude of 10%, with
alternating 10 s pulses and pauses on ice.
For in vivo exposures.  Particles were suspended by
sonication in 1 ml of MilliQ water containing 0.9% NaCl and
10% v/v acellular broncho alveolar lavage (BAL) fluid collected
from C57BL/6 mice. Naïve C57BL/6 mice were flushed twice
with 0.6 ml of 0.9% NaCl to obtain approximately 1 ml of BAL.
BAL was centrifuged at 400 G for 10 min at 4°C to remove cells
and the supernatant was used in the dispersant liquid. The
Mitsui7 (4.05 mg/ml) suspension was sonicated on ice using a
Branson Sonifier S-450D equipped with a disruptor horn
(Model number: 101-147-037) for a total of 4 minutes at
amplitude of 10%, with alternating 10 s pulses and pauses.
This suspension was used for the high dose (162 µg) and
diluted 1:3 in vehicle for the medium (54 µg) dose and diluted
further 1:3 for the low dose (18 µg). Between the dilutions the
suspensions were mixed by pipetting. Vehicle control solutions
were prepared with 0.9% NaCl and 10% acellular BAL fluid and
sonicated as described above.
Dose selection
Table 2 summarizes the doses chosen for in vivo and in vitro
exposures.
In vivo.  Mice were exposed to 18, 54 or 162 µg of Mitsui7/
animal by single intratracheal instillation (these doses are also
referred to as low, medium, and high respectively, in the text
where appropriate). The doses were selected based on our
previous studies [32-36] and reflect 8 h time weighted average
(TWA) for carbon black particles (3.5 mg/m3) in an occupational
setting in Denmark. The lung of an average female C57BL/6
mouse of 20 g weighs 274 mg with an average surface area of
82 cm2. Thus, using surface area of exposure as a parameter,
the doses chosen in the study can be expressed as 0.22, 0.66
and 1.98 µg of Mitsui7/cm2 of lung surface area, respectively.
In vitro.  Cells were exposed to 12.5, 25.0 and 100 µg
Mitsui7/ml (these doses are also referred to as low, medium,
and high respectively in the text where appropriate). These
concentrations were selected based on the concentration
ranges used in the literature that are demonstrated to induce
some degree of cellular response, but that are well below the
Table 2. Comparison of in vivo and in vitro doses.
In vivo exposure doses In vitro exposure concentrations
µg/animal 162 54 18 µg/ml 100 25 12.5
mg/kg 8.1 2.7 0.9 mg/kg NR NR NR
(assuming an average
mouse weighs 20 g)        
mg/kg mouse lung 591 197 65.7 mg/kg NR NR NR
(assuming an average
lung weighs 274 mg)        
µg/cm2 (lung surface:
82 cm2) 1.98 0.66 0.22
µg/cm2 (4-wells
Petri dish:
21.8cm2, 6.8 ml)
31.19 7.8 3.9
NR: Not Relevant
doi: 10.1371/journal.pone.0080452.t002
In Vitro-In Vivo Transcriptomic Responses to MWCNT
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concentrations that induce cytotoxicity (data not shown).
Monolayers were exposed in a 4-well Petri dish consisting of
21.8 cm2 total surface area. The exposure was carried out in a
total volume of 6.8 ml. The in vitro concentrations amount to
3.9, 7.8 and 31.19 µg/cm2 of Petri dish. Thus, the highest in
vivo dose (1.98 µg/cm2) was approximately half of the lowest in
vitro concentration used (3.9 µg/cm2), based on µg Mitsui7/cm2
area.
Cell culture, exposure and sample collection
The development of the MutaTMMouse lung epithelial cell line
(FE1) and its characterization has been previously described
[37]. The FE1 epithelial cells were cultivated in DMEM/F-12 +
GlutaMaxTM-1 (Fisher Scientific Biotech Line A/S, 21765037,
Slangerup, Denmark) supplemented with 2% fetal bovine
serum (In Vitro AS, B1-04-007-1A, Fredensborg, Denmark),
1% penicillin/streptomycin solution (In Vitro AS, B1-03-031-1B,
Fredensborg, Denmark) and 100 ng/μl murine epidermal
growth factor (Sigma-Aldrich, E4127-1MG, Broendby,
Denmark). Cells were maintained in T150 bottle (Thermo
Fisher Scientific, NUN-156502, Roskilde, Denmark) at 37.0°C
with 5% CO2 and 90% humidity. Media was replaced every 2-3
days to ensure proper growth conditions.
FE1 cells were seeded at 105 cells/ml density to a total of
6.81 ml/well in the 4-well plates (NUNC, Thermo Scientific,
Hvidovre, Denmark, 167-063) and incubated at 37°C for 24
hours. The next day cells were examined for overall natural
appearance and growth. At the time of treatment, cells showed
~ 80% confluency. Cells were incubated with 0, 12.5, 25, and
100 µg Mitsui7/ml for 24 h. Following the incubation, cells were
trypsinized and centrifuged to collect cell pellets. The cell
pellets were stored at -80°C until further use. Three individual
experiments were conducted (cells were exposed in separate
experiments).
Animals
Ethics Statement.  All procedure complied with EC Directive
86/609/EEC and Danish laws regulating experiments on
animals (permit 2010/561-1779). Mice did not display any signs
of respiratory distress, lethargy or any other physical symptoms
following exposure.
Female C57BL/6 mice aged 5-7 weeks were obtained from
Taconic (Ry, Denmark). The mice were allowed to acclimatize
for 1-3 weeks before the experiment. All mice were given food
(Altromin no. 1324, Christian Petersen, Denmark) and water ad
libitum during the whole experiment. Mice were group-housed
in polypropylene cages with sawdust bedding at controlled
temperature 21±1°C and humidity 50±10% with a 12-h light:12-
h dark cycle. Experiments were initiated at 8 weeks of age.
Animal exposure and tissue collection.  Mice were
intratracheally instilled as previously described for other
nanomaterials [33,38]. In brief, mice were anesthetized by
subcutaneous injection of 0.2 ml of Hypnorm® (fentanyl citrate
0.315 mg/ml and fluanisone 10 mg/ml, Janssen Pharma) and
Dormicum® (Midazolam 5 mg/mL, Roche) in sterile water. The
mice were kept on their back at a 40-degree angle on a hot
plate (37 °C) during the entire procedure. Mice were exposed
to 18, 54 and 162 µg of Mitsui7 via a single intratracheal
instillation. A 40 µl suspension was instilled followed by 150 μl
air with a 250 µl SGE glass syringe (250F-LT-GT, MicroLab,
Aarhus, Denmark). Control animals were instilled with vehicle
(0.9% NaCl with 10% BAL). After the instillation catheter was
removed, breathing was observed in order to assure that the
delivered material did not block the airways. Mice were allowed
to recover for 24 hours before sacrifice. For tissue collection,
mice were anaesthetized with Hypnorm/Dormicum as
described above and killed by exsanguination via intracardiac
puncture. The right lung lobes were snap-frozen in cryotubes in
liquid N2 and stored at -80°C.
All animal procedures followed the guidelines for the care
and handling of laboratory animals established by the Danish
government. The Animal Experiment Inspectorate under the
Ministry of Justice approved the study (#2010/561-1779). 
Additional animal exposures and tissue collection for
validation by RT-qPCR
The doses chosen for both in vivo (18, 54 and 162 µg of
Mitsui7/animal) and in vitro (12.5, 25, and 100 µg of Mitsui7/ml)
were high [18], therefore, additional animal exposures to lower
doses of Mitsui7 were carried out. Mice were exposed to 2 and
6 µg of Mitsui7 via single intratracheal instillation and samples
were collected at 24 hours following the exposure. In vitro, cells
were incubated with 0.00125, 0.125 and 1.25 µg of Mitsui7/ ml
and cells were harvested at 24 hours post-exposure time point.
Exposure of animals and sample collection is described above.
Tissue samples collected from this exposure were used for
validation by RT-qPCR.
Transmission Electron Microscopy
For transmission electron microscopy (TEM), mice were
euthanized and lungs were fixed for a week in a 2%
glutaraldehyde buffered fixative (pH 7.2) via trachea. Fixed
lung was cut in small pieces and a standard Electron
Microscope embedding procedure was carried out. Samples
were rinsed in 0.15 M phosphate buffer followed by a wash
with 0.15 M sodium cacodylate. Post-fixation and osmofication
were carried out in 2% osmium tetroxide in 0.05 M potassium
ferricyanide for 2 hours. Following osmofication, samples were
rinsed in deionized water and placed in 1% uranyl acetate in
water overnight at 5 °C. The following day samples were
gradually dehydrated in ethanol and lastly in propylene oxide.
Embedding was performed in propylene oxide diluted Epon,
until 100% Epon 812 was used before polymerisation at 60 °C
for 24 hours. Samples were cut into approximately 80 nm
sections for TEM using an ultramicrotome with a diamond
knife. Sections were stained with uranyl acetate and lead
citrate, and imaged using a CM 100 BioTwin instrument from
Philips operated at 80 kV accelerating voltage.
BAL cell counts
Infiltration of inflammatory cells into lung lining fluid was
determined by BAL done immediately after cardiac puncture
and collection of blood. The statistical analyses were
performed in SAS version 9.2 (SAS Institute Inc., Cary, NC,
USA). Statistical significance was calculated using a non-
In Vitro-In Vivo Transcriptomic Responses to MWCNT
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parametric one-way ANOVA with a post-hoc Tukey-type
experimental comparison test.
Total RNA extraction
Total RNA was isolated from cell samples (n = 6 replicates
per concentration) and from lung tissue of 72 mice in total (n =
6 mice per dose group). Isolations were done using TRIzol
reagent (Invitrogen, Carlsbad, CA, USA) and purified using the
RNeasy MiniKit (Qiagen, Mississauga, ON, Canada ) as
described by the manufacturer. An on-column DNase treatment
was applied (Qiagen, Mississauga, ON, Canada). All RNA
samples showing A260/280 ratios between 2.0 and 2.15 were
further analysed for RNA integrity using an Agilent 2100
Bioanalyzer (Agilent Technologies, Mississauga, ON, Canada).
RNA integrity numbers above 7.0 were used in the experiment.
If the RNA samples didn’t reach the criteria, new RNA
extractions from the lung tissue or cell culture were performed.
Total RNA was stored at -80°C until analysis.
Microarray Hybridization
Total RNA (200 ng) from each sample (n=6 per group) and
from universal reference RNA (UMRR, Stratagene,
Mississauga, ON, Canada) was used to synthesize double-
stranded cDNA and cyanine labeled cRNA using the Agilent
Linear Amplification kit (Agilent Technologies, Mississauga,
ON, Canada ). Reference RNA was labeled with cyanine 3-
CTP and experimental samples were labeled with cyanine 5-
CTP (Agilent Technologies Inc., Mississauga, ON, Canada).
The cyanine-labeled cRNA was in vitro transcribed using T7
polymerase and purified using RNeasy mini kits (Qiagen).
Sample and reference targets (825 ng) were combined and
hybridized to Agilent 8 x 66K oligonucleotide microarrays
(Agilent Technologies Inc., Mississauga, ON, Canada) for 17
hours at 65°C. The arrays were washed according to supplier
instructions and then scanned on an Agilent G2505B scanner
at 5 µm resolution. Data were acquired using Agilent Feature
Extraction software version 9.5.3.1
Statistical Analysis of Microarray Data
A reference design [39-41] with the sample labelled with Cy5
and the reference labelled with Cy3 was used to analyze the
data. The quantified data for each array was read into R
[42,43]. The median signal intensity without background
subtraction was used in this analysis and probes with technical
replicates were averaged using the median. The background
for each array was measured using the (-)3xSLv1 probe. Spots
with median signal intensities less than the trimmed mean (trim
= 5%) plus three trimmed standard deviations of the (-)3xSLv1
probe were flagged as below detection (i.e., absent). The total
number of flagged spots, the median signal intensity and
standard deviation for the (-)3xSLv1 probe for each array were
recorded. Other microarray level summary statistics included
the median signal to noise ratio (log2 scale) and the median
signal intensity for each channel as well as the median
absolute deviation. Differentially expressed genes between the
control and treated groups were determined using the
MAANOVA library [44]. The ANOVA model included treatment
and a slide effect. This model was applied to the log2 of the
relative intensities. The Fs statistic [45], a shrinkage estimator
for the gene-specific variance components was used. The p-
values for all the statistical tests were estimated using the
permutation method (30,000 permutations with residual
shuffling). These p-values were then adjusted for multiple
comparisons by using the false discovery rate approach (FDR)
[46]. Estimated marginal means, also known as least square
means [47,48], were estimated for each group. These means
are a function of the model parameters and are adjusted for the
other factors in the model such as day of hybridization. The
least square means were then used to estimate the fold
change for each contrast that was tested.
Quantitative Real Time (qRT)-PCR array validation
Fifty-four individual genes from each cells and tissues were
selected for further validation by RT-qPCR using custom RT2
Profiler PCR Arrays and a BioRad CFX96 Real-Time PCR
detection system. The genes selected were statistically
significant in the DNA microarray analysis for at least one
condition and were associated with three biological functions:
oxidative stress, inflammation and fibrosis. A custom RT2
Profiler PCR Array plate, the RT2 First Strand Kit and RT2
SYBR® Green qPCR Mastermix (QIAGEN Sciences, Maryland,
USA) were used. Hypoxanthine-guanine
phosphoribosyltransferase (Hprt), actin β (Actb) and
glyceraldehyde 3-phosphate dehydrogenase (Gapdh) were
used as reference genes for normalization and were selected
based on their stable expression levels in the treated and
control samples in the microarray results. A threshold value
was set to 102. The final RT-qPCR validation group consisted
of a sample size of n=3 for both cells (individual passages) and
tissues (individual animals).
Results and Discussion
We exposed mice and mouse lung epithelial cells in culture
to three different doses of Mitsui7 to evaluate the efficacy of in
vitro models to predict in vivo outcomes following exposure to
ENM. Lung tissues and cell lysates were collected 24 hours
post-exposure. Global gene expression profiling was employed
to characterize the molecular differences and similarities
between in vivo and in vitro models as they relate to the
existing mechanistic information available on the MWCNT-
induced toxic effects.
Dose and concentration selection
In vivo doses chosen for this study were based on our
previous studies and reflect 1, 3, and 9 days of 8 h time
weighted exposure limit for carbon black particles (3.5 mg/m3)
in an occupational setting in Denmark. In vitro doses were
chosen to mimic the total lung surface area available for
exposure to particles (Table 2). At present, there are no
occupational exposure limits specified for MWCNT in Denmark.
Taking into consideration the MWCNT aerosol levels found in
an occupational environment, the mass median aerodynamic
diameter of MWCNT, and the surface area of human alveolar
epithelium, Porter et al. [18] calculated that exposure of mice to
10 µg MWCNT is close to one month of human exposure to
In Vitro-In Vivo Transcriptomic Responses to MWCNT
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aerosol concentrations of 400 µg/m3 MWCNT in the work
environment [18,49]. Mice exposed to 10 µg of MWCNT exhibit
transient inflammation, which subsides at 7 days post-
exposure. In contrast, mice exposed to 20 and 40 µg MWCNT
displayed prolonged inflammation up to 56 days post-exposure,
and fibrosis-like conditions are observed following exposure to
80 µg MWCNT [18,50]. The Mitsui7 instillation doses used in
the present study span this entire exposure range [18,50].
An aerosol concentration of 440 µg/m3 is approximately
equivalent to human alveolar epithelium exposed to 226 µg/m2
MWCNT per month, which is less than 1 µg/ml concentration
for cells exposed in culture medium [18]. Thus, according to
these calculations, the in vitro Mistui7 concentrations chosen in
the present study are approximately an order of magnitude
higher than potential human exposures (the lowest
concentration being 3.9 µg/ml), as well as approximately an
order of magnitude higher than the mouse in vivo exposures.
However, we note that the lowest in vitro dose (12.5 µg) is
similar to the highest in vivo dose (162 µg) delivered. These
very high doses were chosen because they reflect the present
literature on MWCNT-induced effects.
Mitsui7 characteristics in the dispersion medium
The particle size of Mitsui7 in the in vivo and in vitro
exposure dispersion medium was determined using dynamic
light scattering (DLS; File S1). The DLS technique measures
spherical hydrodynamic diameter and since Mitsui7 exhibit rod-
like shapes, it is not clear what the size-spectra of Mitsui7
generated by DLS corresponds to. Size scatter may very well
include signals arising from more than one MWCNT dimension
and metal impurities; however, the sizes may reflect the
hydrodynamic equivalent size distributions. The distribution
used in this study is number size distribution. The DLS is used
only as an indication of the successful dispersion of the
MWCNT and caution must be exercised when interpreting DLS
data.
The DLS of unfiltered Mitsui7 in the in vivo exposure medium
(0.9% NaCl with 10% BAL) showed a slightly skewed unimodal
size distribution with a peak size at ca. 5000 nm (Figure S1A).
The average zeta size was 8719.8 nm. The polydispersity
index (PDI) was 1.0, indicating the presence of large Mitsui7
agglomerates of different sizes. After filtration through a 3.1 μm
filter, DLS showed a multimodal size distribution with peak
sizes at ca. 600 nm, 1000 nm, and 2000 nm, and an average
zeta size of 1701.8 nm, thus indicating the presence of smaller
agglomerates (Figure S1A). A PDI of 0.658 was found,
demonstrating better dispersion after filtration. The in vivo
exposure medium was analyzed separately and showed a
bimodal size distribution with peak sizes at ca. 85 nm and 250
nm, an average zeta size of 389.9 nm (Figure S1B), and a PDI
of 0.717, indicating protein agglomerates of various sizes.
Filtration of the exposure medium through a 0.2 μm filter
revealed the presence of smaller proteins with peak sizes of 25
nm and 55 nm, and an average zeta size of 67.2 nm.
The in vitro exposure medium (DMEM-F12 cell culture
medium with 2% fetal bovine serum) was also analyzed with
and without Mitsui7. The analysis of unfiltered Mitsui7 in the in
vitro exposure medium showed a unimodal size distribution
with a peak size at ca. 370 nm (Figure S1C). The average zeta
size was 368.6 nm and the PDI was 0.406, indicating well-
dispersed Mitsui7. A separate analysis of in vitro exposure
medium alone showed a unimodal size distribution with a peak
size of 5.5 and a zeta average of 14.5 (Figure S1D).
SEM was performed on both pristine Mitsui7 and Mitsui7 in
the exposure medium used for both in vivo and in vitro
exposures. At all magnifications Mitsui7 appeared intertwined
and agglomerated, with both long and straight, and bended
tubes (Figures 1A and 1B). Crystalline impurities were
observed on the Mitsui7 that may have originated from the
dried exposure medium. SEM images of the pristine Mitsui7
are shown in Figure 2A-C. At low quantities, the pristine Mitsui7
appeared long and straight, but at the higher densities
agglomerates were observed, with somewhat intertwined and
bended tubes. Figures 3A and 3B show light microscopy
images of Mitsui7 dispersed by sonication in the in vitro
exposure medium. Samples appeared well-dispersed at all
doses. Cytotoxicity following exposure to the indicated doses of
Mitsui7 was assessed in vitro previously and revealed no
toxicity (NR Jacobsen, unpublished).
TEM was performed on both pristine Mitsui7 tubes and in the
lung lining of the mice intratracheally instilled with Mitsui7. As
with SEM, the pristine Mitsui7 appeared long and straight, and
although agglomeration was observed, the rigid structure
remained (Figure 4A). Diameter of the pristine tubes was
measured to 74.4 nm (SD 27.2). Images of Mitsui7 found inside
a cell three days after exposure are shown in Figures 4B, the
MWCNTs have been partially dislodged during ultramicrotomy.
An image of Mitsui7 enclosed in an alveolar macrophage three
days after exposure are shown in Figures 4C. No tubes are
seen penetrating the macrophage, but several tubes appear to
have been engulfed and are enclosed in vesicles. This clearly
shows interaction between Mitsui7 and inflammatory cells in
the alveolar region.
BAL fluid cellular composition
BAL fluid was collected from Mistui7-instilled mice 24 hours
after the exposure to assess the recruitment of inflammatory
cells into the lung lumen. The total number of cells, neutrophils,
macrophages, eosinophils, and lymphocytes were counted and
the results are shown in Table 3. The lung inflammatory
response was characterized by an increase in the total number
of cells that was predominantly the result of a dose-dependent
increase in neutrophils (7.2 - 18.2-fold increase over controls).
Although a statistically significant increase in the total number
of eosinophils was observed in all the dose groups compared
to the vehicle treated controls (129.3, 77 and 7.3-fold increase
at 18, 54 and 162 μg doses (0.22, 0.66 and 1.98 µg/cm2),
respectively), an inverted dose response was found, with the
highest eosinophil influx found at the lowest dose. Specifically,
a 17.6-fold reduction in the number of eosinophils was
observed from the lowest dose to the highest dose. A similar
trend was observed for the total number of lymphocytes; there
was a non-significant increase in the number of lymphocytes in
the BAL of the low dose group mice (1.8 fold increase over
matched controls) that decreased significantly with increasing
dose (0.4 fold compared to matched controls at the high dose).
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Figure 1.  SEM images of Mitsui7 in the in vivo exposure medium.  (A) High density behavior of Mitsui7 (B) Long, straight, and
bended tubes are visible. Impurities seen on the MWCNTs may be dried materials from the exposure medium.
doi: 10.1371/journal.pone.0080452.g001
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Figure 2.  SEM images of dry, pristine Mitsui7.  (A) Mitsui7 at high density. (B) A close-up of MWCNT at high density. (C) Mitsui7
behavior at low density.
doi: 10.1371/journal.pone.0080452.g002
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In contrast, the total number of macrophages decreased in a
dose-dependent manner relative to controls with a significant
decrease found in the highest dose group (0.6 fold) compared
to the vehicle treated matched controls.
Our results showing increased neutrophil and decreased
macrophage populations are consistent with Ma-Hock et al.
[11]. However, these studies did not show increases in
eosinophils. Although a sharp increase in the total number of
eosinophils following exposure to low dose of Mitusi7 may be
indicative of allergic airway inflammation [51], it is not clear
from the observations why eosinophilia decreased with
increasing dose. A similar decline in the total number of
eosinophils in the lungs of rats exposed to increasing doses of
nano-SiO2 was reported [52]. In a murine model of asthma,
polymerized liposome nanoparticles were shown to mimic
physiological ligand 1 and bind to P selectin on activated
airway endothelium. Furthermore, competitive binding of
nanoparticles to P selectin was shown to inhibit eosinophil
activation resulting in reduced eosinophil-mediated
inflammatory response, a hallmark of allergic airway disease
[53]. These results support the hypothesis that high doses of
Mitsui7 could be competing with physiologic- ligand 1 (required
for activation of P selectin) to bind to P selectin on the activated
endothelium thereby inhibiting the recruitment of eosinophils
into the BAL. A similar argument can also be made for the
observed decreases in the lymphocyte population at higher
doses.
Figure 3.  Light microscopy images of Mitsui7 dispersed in the in vitro exposure medium after sonication.  (A) 100 μg/
milliliter (31.19 µg/cm2) concentration (B) 12.5 μg/ml concentration (3.9 µg/cm2). Bars represent 50μm.
doi: 10.1371/journal.pone.0080452.g003
Figure 4.  TEM images.  (A) Pristine Mitsui7 (B) Mitsui7 MWCNTs interacting with cells in the lung lining fluid (Black arrows). The
MWCNTs have been partially dislodged during ultramicrotomy (C) Macrophage containing engulfed Mitsui7 in vesicle (red arrow).
doi: 10.1371/journal.pone.0080452.g004
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Microarray analysis
All microarray data have been deposited in the NCBI Gene
Expression Omnibus database and can be accessed through
the accession number GSE47000. A total of 4,259 of the
60,000 probes on the array were expressed (where expressed
is defined as probes having signal intensities above
background in 4 out of 5 samples in at least one experiment
condition) in both cells and tissues. Differentially expressed
genes were identified using MAANOVA; a probe was
considered to be differentially expressed if its normalized signal
intensities in treated samples were significantly different from
control values following FDR adjustment, with P ≤ 0.05, and the
relative change in expression (fold change) was at least ±1.5 in
either direction.
Overview of in vivo microarray results
In general, a high degree of reproducibility was observed
within control and treated replicates. A total of 1635 unique
genes represented by 2104 probes were significantly
differentially expressed in the lungs following exposure to 18,
54, and 162 µg of Mitsui7 at the 24 hours post-exposure time
point. A total of 601 (383 genes down-regulated and 219 up-
regulated), 114 (35 down-regulated and 79 up-regulated) and
1353 (754 down-regulated and 601 up-regulated) genes were
differentially expressed in the 18, 54, and 162 µg dose groups,
respectively. These genes are listed in the Table S1. Only 46
genes were commonly differentially expressed in all three dose
groups (Figure 5A). Most of the genes in this list exhibited a
dose-response and were mainly associated with acute phase
response, immune cell trafficking, lung hypersensitivity, and
hematological system functions. Increased expression of acute
phase response genes (including Saa1, Saa3 and Timp1) has
also been reported in the lungs of mice exposed to nano-sized
titanium dioxide [54,55] and nano- particles of carbon black
[56], suggesting acute phase genes are sensitive markers of
exposure to nanoparticles [57]. A list of the significant genes
that were responsive in all dose groups is provided in Table 4.
Table 3. Differential cellular counts in the bronchoalveolar
lavage fluid.
Cell types Dose (µg/animal)
 Control 18 54 162
Neutrophils x 103
(%)
7.7 ± 1.7
(10.4)
55.1 ± 10.6
(38.6)*
60.6 ± 4.5
(44.5)*
140.2 ± 31.9
(71.8)*
Macrophages x 103
(%)
53.2 ± 2.5
(72.1)
38.2 ± 5.1
(26.8)
37.4 ± 7.4
(27.8)
30.3 ± 8.5
(15.5)*
Eosinophils x 103
(%)
0.3 ± 0.1
(0.4)
38.8 ± 10.7
(27.2)*
23.1 ± 11.1
(17.1)*
2.2 ± 0.5
(1.1)*#
Lymphocytes x 103
(%)
1.6 ± 0.5
(2.2)
2.8 ± 0.5
(2.0)
1.7 ± 0.5
(1.3)
0.6 ± 0.3
(0.3)*#
Total BAL Cell x 103 73.8 ± 3.6 142.8 ± 22.3* 134.7 ± 19.5* 195.3 ± 40.8*
Statistically significant (P<0.05) difference between (*) treated and controls, and
(#) low (18 µg) and high (162 µg) doses.
doi: 10.1371/journal.pone.0080452.t003
We analyzed the gene ontology (GO) classifications of all of
the differentially expressed genes to identify themes in the
global pulmonary gene expression patterns following exposure
to Mitsui7. The processes affected by MWCNT are shown in
Figures 5B and 5C, and include ‘common’ (i.e., occurring in
more than one group) and ‘unique’ (i.e., occurring in one dose
group only) processes, respectively. Processes involved in
chemotaxis [GO: 6935], immune response [GO: 6955],
inflammatory response [GO: 6954], oxidative reduction [GO:
55114] and behavior [GO: 7610] were over-represented among
all the dose groups (Figure 5B). In addition, several unique GO
processes were over-represented within a dose group (Figure
5C). In the low dose group, the top biological processes altered
consisted of 70 genes involved in cell cycle and was
associated with five specific GO terms: cell cycle [GO: 7049],
cell cycle process [GO: 22402], cell cycle phase [GO: 22403],
M phase [GO: 279], and cell division [GO: 51301]. The other
over-represented biological processes in the low dose group
included: microtubules [GO: 7017], nucleosome assembly [GO:
6334], meiosis [GO: 7126], ear morphogenesis [GO: 42471],
regulation of cell substrate adhesion [GO: 10810], and
complement activation, alternate pathway [GO: 6957]. In the
medium dose group, negative regulation of cell proliferation
[GO: 42127] and positive regulation of response to stimulus
[GO: 48584] were uniquely enriched with 14 genes in each of
the processes. Unique biological processes affected in the high
dose group included: cell motion [GO: 6928], vasculature
development [GO: 1944], response to hormone stimulus [GO:
9725], regulation of inflammatory response [GO: 50727], and
negative regulation of response to stimulus [GO: 48585].
In order to understand the functional significance of these
GO changes, Ingenuity Pathway Analysis (IPA Reference) was
employed to identify biological networks, functions, and
pathways affected in all of the dose groups. Table 5 shows a
summary of the top functions and processes altered in the
three dose groups 24 hours following the exposure to Mitsui7.
This analysis revealed that biological functions such as, cellular
movement, cellular growth and proliferation, and cell-to-cell
signaling were commonly affected across the dose groups.
Closer examination of these differentially expressed genes
under each of the functional categories in common revealed
that they are actually specifically involved in immune and
inflammation related responses. Analysis of biological
pathways revealed significant enrichment of genes in the
pyrimidine ribonucleotides de novo synthesis, aryl hydrocarbon
receptor signaling, and LPS/IL-1 mediated inhibition of RXR
signaling pathways in the low dose group. In the medium dose
group, genes involved in the acute phase response signaling,
chemokine signaling and IL-17 signaling pathways were
significantly enriched. Finally, retinol biosynthesis, neuregulin
signaling, and acute phase response signaling were the most
affected pathways in the high dose group.
A detailed study of a subset of genes implicated in the
processes mentioned above revealed dose-specific responses
ranging from imbalances in nucleotide synthesis in the low
dose to inflammation, angiogenesis and lipid metabolism
related effects in the high dose. For instance, we found
significant down-regulation of adenylate kinase 8 (-2.1 fold),
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ectonucleoside triphosphate diphosphohydrolase 2 and 8 (-1.9
and -2.0 fold), and nucleoside diphosphate kinase 5 (-2.1) in
the low dose. These genes are actively involved in the
synthesis and metabolism of uridine-5’-triphosphate (UTP) and
adenosine triphosphate (ATP) nucleotides required for the
maintenance of ion homeostasis in the lungs [58,59].
Decreased synthesis and depletion of pyrimidine nucleotides
prevents blockade of the epithelial sodium channels, increase
Figure 5.  Overview of response in the lung tissue.  (A) Venn diagram showing the overlapping differentially expressed genes
(FDR P ≤ 0.05 and fold change ≥ 1.5) in response to low (18 µg, green), medium (54 µg, blue), and high (162 µg, red) doses of
Mitsui7 in the lung tissues. (B-C) Gene ontology (GO) analysis of differentially expressed genes. (B) Commonly regulated GO
biological processes, and (C) GO biological processes unique to the low, medium, and high dose groups. Numbers in parentheses
represent number of genes altered in that process.
doi: 10.1371/journal.pone.0080452.g005
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alveolar fluid clearance and clearance of lung edema in mice
infected with respiratory syncytial virus and influenza A virus
[58-60]. Metabolism of adenine nucleotides in human airway
Table 4. Differentially expressed genes common across all
three doses.
Gene symbol Entrez ID
Average fold change compared to matched
controls
  18 µg/mouse 54 µg/mouse 162 µg/mouse
A130040M12Rik 319269 1.8 2.3 2.7
Adamts4 240913 1.8 2.4 3.5
Adm 11535 1.9 2.2 3.0
Asgr1 11889 -2.2 -3.1 -2.3
Bcl3 12051 1.6 1.7 1.7
Ccdc129 232016 -3.0 -2.3 -2.7
Ccl11 20292 3.0 5.2 3.4
Ccl17 20295 3.5 3.4 2.8
Ccl2 20296 3.6 5.3 4.0
Ccl7 20306 5.5 6.9 4.3
Ch25h 12642 2.7 3.1 4.0
Cldn8 54420 -2.0 -1.8 -2.0
Ctps 51797 2.0 2.7 2.9
Cxcl1 14825 2.3 3.9 4.7
Entpd8 72090 -2.0 -2.1 -2.4
Gm2045 100039096 2.1 2.5 4.4
Gm2371 100039687 1.7 2.1 2.8
Gm3459 100041663 2.0 2.7 3.9
Gm4148 100042984 2.0 2.1 3.0
Gm4382 100043353 2.1 1.9 2.5
Gm4499 100043524 2.0 2.5 3.6
Gprasp1 67298 -1.6 -1.7 -2.6
Has1 15116 1.9 2.3 1.8
Hbegf 15200 1.8 2.6 2.0
Il6 16193 2.6 3.9 6.2
Klhl24 75785 -1.9 -1.9 -1.8
Mt2 17750 2.7 11.7 27.5
Myb 17863 -1.9 -2.1 -2.2
Osbpl6 99031 -1.8 -1.6 -1.9
Rgs16 19734 1.8 2.1 2.5
Rrbp1 81910 1.6 1.6 1.6
Serpina3g 20715 3.2 3.4 3.4
Serpinf1 20317 -1.7 -1.7 -1.7
Six4 20474 -1.7 -1.7 -2.1
Slc26a4 23985 9.0 7.7 5.3
Slc30a2 230810 -2.2 -1.9 -1.9
Slc39a14 213053 1.6 2.3 3.7
Saa1 20208 3.8 7.0 12.3
Saa3 20210 9.9 12.3 45.6
Timp1 21857 7.7 9.7 11.7
Tnfrsf12a 27279 1.6 2.4 2.7
Tnfsf9 21950 2.0 2.1 2.4
Trib1 211770 1.5 1.7 1.6
Trmt61a 328162 1.8 1.8 1.7
Tubb6 67951 1.8 1.8 1.6
Tyro3 22174 -1.6 -1.6 -2.0
doi: 10.1371/journal.pone.0080452.t004
epithelial surfaces plays a role in the regulation of mucociliary
clearance related epithelial functions. Imbalances in this
pathway can lead to inhibition of sodium ion transport leading
to accumulation of alveolar fluid and pulmonary edema. Excess
ATP in the lung fluids is suggested to contribute to the onset of
inflammation in humans suffering from pulmonary pathology
including alveolar damage, inflammation and edema (reviewed
in 61. Enrichment of de novo pyrimidine synthesis pathway in
the low dose group may thus reflect a non-specific cellular
response to invasion of lungs with particles, possibly an effort
leading to their clearance. In the medium dose, a dramatic up-
regulation of several acute phase and inflammation associated
genes such as Saa3 (12.3-fold), Saa1 (7.0 fold), Saa2 (12.0
fold), Il6 (4-fold), Ccl7 (7.0 fold), Ccl11 (5-fold), Ccl13 (6.0 fold),
and Ccl24 (10.0 fold) was noted. These changes suggest an
active recruitment of inflammatory cells to the site of exposure
aiding in clearance efforts. These genes are also affected by
the high dose. However, in addition to a significant up-
regulation of genes implicated in acute phase and inflammation
pathway in the high dose, down regulation of
carboxylesterases 2C and 2E (-1.7, -2.1 fold), dehydrogenase
reductase (-1.6 fold), retinol binding proteins 1 and 7 (-1.7, -2.4
fold), lecithin retinol acyltransferase (-3.0 fold) and up-
regulation of esterase D (1.65 fold), lipoprotein lipase (2.5 fold),
lipase-hormone sensitive (2.5 fold), amphiregulin (3.0 fold),
epiregulin (2.8 fold) were noted. These genes are involved in
functions such as angiogenesis, lipid metabolism, and cellular
proliferation. Combined analysis of all genes altered under
these pathways using the GeneGo Metacore map creator tool
revealed that of the 80 genes associated with the pathways
described above, 60 were commonly regulated by E2f1 (a cell
cycle regulatory transcription factor), Il6 (an inflammatory
modulator) and C-myc (an oncogene). We note that these
regulators were also significantly differentially expressed in the
treated groups (Figure 6).
In general, the above results reveal a clear distinction in
tissue response across the doses. The response in the lowest
(18 μg or 0.22 µg/cm2) dose was marked by a negative
regulation of the cell cycle process, in parallel with changes in
the nucleotide metabolism and synthesis pathways. Cell cycle
arrest and imbalance of nucleotide metabolism can be viewed
as early regulatory signals initiating an organism’s defense
functions including phagocytic mopping and airway clearance
mechanisms in lungs. This was evident in the medium dose (54
μg or 0.66 µg/cm2), which showed positive regulation of acute
phase response and inflammatory mediators. In the high dose
(162 μg or 1.98 µg/cm2), the overall response was much
greater than the other two dose groups and included
simultaneous enrichment of several biological processes
including inflammation, acute phase response, angiogenesis,
pro-and anti-fibrotic factors, and anti-oxidants.
Overview of in vitro microarray results
Lung epithelial cell monolayers were exposed to 12.5 (low),
25.0 (medium) and 100 μg (high) Mitsui7/ml (corresponding to
3.9, 7.8 and 31.19 µg/cm2, respectively) for 24h as described in
methods and materials. MAANOVA analysis was applied to
identify differentially expressed genes. This gene list was
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filtered to remove probes that were below our detection
threshold (i.e., probes that were not expressed above
background levels). This analysis revealed a total of 1931
unique genes represented by 2413 probes that were
significantly differentially expressed (FDR adjusted P<0.05 and
±1.5 fold change) in the cells exposed to 12.5, 25 or 100 μg
Mitsui7/ml (3.9, 7.8 and 31.19 µg/cm2). A dose-dependent
increase in transcriptional effects was found, with a total of 782
(432 genes down-regulated and 350 up-regulated), 1337 (682
down-regulated and 655 up-regulated), and 1721 (921 down-
regulated and 801 up-regulated) genes differentially expressed
in the 12.5, 25 and 100 μg Mitsui7/ml (3.9, 7.8 and 31.19
µg/cm2) groups, respectively. The full list of significant genes is
available in Table S2. A total of 565 genes were affected by
every concentration of Mitsui7 (Figure 7A). Most of the genes
that were affected in the medium and high concentration
groups were also affected in the low concentration group
(Figure 7A) and were mainly associated with Aryl hydrocarbon
receptor (AHR) signaling, glutathione mediated detoxification,
acute phase response signaling, cholesterol biosynthesis,
hepatic fibrosis/hepatic stellate activation, and NRF2 mediated
oxidative stress response. A list of genes affected in common
for every concentration analyzed is provided in Table S3.
To be consistent with the analysis conducted on in vivo
microarray results, we employed GO functional classification to
assign specific functional or biological processes to the
differentially expressed genes following in vitro exposure to
Mitsui7. The common and unique biological processes
significantly enriched in different exposure groups across the
dose groups are shown in Figures 7B and 7C. Processes
involved in steroid biosynthetic process [GO: 16126],
vasculature development [GO: 1944], regulation of cell
proliferation [GO: 42127], response to protein stimulus [GO:
51789], and ncRNA metabolic process [GO: 34660] were the
commonly over-represented GO groups (i.e., consistently
appearing within two or three exposure groups) and consisted
of 96 genes. In the medium and high concentration groups
these processes were further represented with GO terms such
as blood vessel morphogenesis [GO: 48514], angiogenesis
[GO: 1525], and positive regulation of cellular proliferation [GO:
8284]. Several GO processes were uniquely altered in the high
concentration group and included oxidation reduction [GO:
55114], response to hypoxia [GO: 1666, GO: 70482], cell cycle
arrest [GO: 7050], cell death [GO: 8219, GO: 16265, GO:
12501], organ development [GO: 48568, GO: 60348, GO:
42724, GO: 51216, GO: 1501, GO: 48705], extracellular matrix
organization [GO: 30198], regulation of activity [GO: 51338,
GO: 45859, GO: 43549, GO: 44092], and lipid biosynthetic
process [GO: 8610]. Of particular interest, and in contrast to
our in vivo findings, analysis of GO processes and functions
revealed a high degree of overlap across the exposure groups,
with exceptions generally only occurring at the highest
concentration. This suggests that although the number of
genes and the magnitude of change (i.e., fold change)
exhibited a dose-response, there was no accompanying
concentration-dependent increment in the nature of toxicity.
Thus, the results indicate that the lowest concentration itself
Table 5. Significantly enriched canonical pathways and networks in in vivo exposure.
 Canonical Pathways Networks
Dose Group  Name  No. of Genes*   Name  No. of Genes*
18 μg Pyrimidine ribonucleotides de novo biosynthesis 7 Organismal injury and abnormalities 27
 Aryl hydrocarbon receptor signaling 13 Cell-to-cell signaling and interaction, immune cell trafficking 25
 LPS/IL-1 mediated inhibition of RXR function 16 Cancer, respiratory disease, cell cycle 22
 Glutathione-mediated detoxification 4 Embryonic development, organ development, organismal development 22
 LXR/RXR activation 9 Cell cycle, cancer 19
 Estrogen-mediated S-phase entry 4 Cellular assembly and organization, cellular function and maintenance,connective tissue development and function 18
54 μg Acute phase response signaling 9 Cellular movement, immune cell trafficking 24
 Chemokine signaling 5 Cancer, organ morphology 16
 IL-17 signaling 5 Organismal injury and abnormalities, inflammatory response 16
 Pyrimidine ribonucleotide de novo biosynthesis 3 Lipid metabolism, molecular transport, small molecule biochemistry 6
 LXR/RXR activation 5 Cell morphology, cell-mediated immune response 1
 Retinoate biosynthesis I 3 Cell-to-cell signaling and interaction, cellular assembly and organization 1
162 μg Retinol biosynthesis 10 Cellular movement, cellular assembly and organization, cellular functionand maintenance 33
 Neuregulin signaling 16 Cellular movement, cell death and survival, drug metabolism 30
 Acute phase response signaling 23 Infectious disease, organismal injury and abnormalities, cell morphology 29
 Role of tissue factor in cancer 16 Lipid metabolism, molecular transport, small molecule biochemistry 29
 Aldosterone signaling in epithelial cells 20 Cellular development, cellular growth and proliferation 28
 Glucocorticoid receptor signaling 29 Cell-mediated immune response, cellular development, cellular functionand maintenance 28
*. Number of genes significantly regulated in each pathway or network
doi: 10.1371/journal.pone.0080452.t005
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was capable of inducing a similar response/toxicity as what
was observed in the medium and high exposure groups.
To identify potential biological pathways affected by MWCNT
exposure in lung epithelial cells, the significant gene list (Table
S2) was overlaid onto molecular canonical pathways in IPA.
Four major canonical pathways were identified as commonly
affected in all the three dose groups: hepatic fibrosis/hepatic
stellate cell activation, aryl hydrocarbon receptor signaling,
super pathway of cholesterol biosynthesis, and glutathione-
mediated detoxification. The majority of the genes implicated in
these pathways were down-regulated. Table 6 lists all of the
genes involved in these four pathways. Gene interaction
networks were then created to visualize the linkages between
the different genes and pathways using the IPA network tool.
Figure 8 shows the three top scoring networks within each
concentration merged into a single concentration-specific meta-
network. In the low concentration, organ development,
cardiovascular system development and function, and cancer
Figure 6.  Gene network.  Combined analysis of all significantly differentially expressed genes associated with angiogenesis, lipid
metabolism, and cellular proliferation pathways in lungs in the high dose group. Analysis was conducted and the network was built
using GeneGo Metacore map creator. The figure shows that the majority of the genes are commonly regulated by E2f1, Il6 and C-
myc. Hexagons represent physical and functional interactions: TR – transcription regulation, IE - influence on expression, B –
binding, and GR – group. The green arrows represent positive regulation/activation, the brown arrows represent negative regulation/
inhibition and the grey arrows represent unspecified regulation.
doi: 10.1371/journal.pone.0080452.g006
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networks were merged. The network consisted of several
nodes including: C-fos, Crem1, Ctgf, Cebpa, and Ahr. In the
medium exposure group, cellular growth and proliferation,
organismal development and drug metabolism, and glutathione
depletion networks were merged. This network consisted of
core nodes including; alpha catenin, Ptgs2, Ahr, Myc, and Nrf2.
In the high concentration, cellular development, lipid
metabolism, cell cycle and tissue development networks were
merged with Cebpa and Cebpb, Hmga1, Ptgs2, and Fos as the
main nodes.
Overall, in vitro lung epithelial cells showed a robust
response to Mitsui7 with alterations in numerous critical
functions including gene expression (expression of many
transcription factors were altered), metabolism, cellular growth
and proliferation, and these changes were found in genes
involved in numerous potential diseases such as cancer and
fibrosis. However, the response was not dose-dependent;
major biological processes and functions altered in the high
(100 μg/ml or 31.19 µg/cm2) concentration were also altered
significantly in the lowest (12.5 μg/ml or 3.9 µg/cm2) exposure
group, suggesting that the lowest dose chosen was sufficiently
high to cause the severe cellular damage.
Comparison of gene expression profiles of in vivo lung
tissue and in vitro lung epithelial cells
In order to determine the relevance of responses observed in
cultured lung epithelial cells following exposure to Mitsui7 to in
vivo lung responses, we analysed all differentially expressed
genes (compared to unexposed control) from both cell cultures
and tissues using IPA’s function analysis tool. Three categories
were included in the analysis: Diseases and Disorders,
Molecular and Cellular Functions and Physiological System
Development and Function. More than 10 individual high-level
processes were significantly enriched and in common to both
cell cultures and tissues under each of the three categories.
We filtered these high level individual functions by 1) removing
redundant functions with overlapping genes, and 2) removing
functions that were not directly relevant to the present study
(e.g. renal diseases, auditory diseases etc.). The final list of the
top most significantly affected high-level biological functions
are shown in Figures 9A and 9B.
Figure 7.  Overview of response in FE1 cells.  (A) Venn diagram showing the overlapping differentially expressed genes (FDR P
≤ 0.05 and fold change ≥ 1.5) in response to low (12.5 µg, green), medium (25 µg, blue), and high (100 µg, red) doses of Mitsui7 in
vitro. (B-C) Gene ontology (GO) analysis of differentially expressed genes. (B) Commonly regulated GO biological processes (C)
GO biological processes unique to the high dose group. Numbers in parentheses represent number of genes altered in that
process.
doi: 10.1371/journal.pone.0080452.g007
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Since the objective was to directly compare the responses in
both cells in culture and tissues, we chose to analyze two high-
level functions in detail systematically. Cellular growth and
proliferation was one of the top high-level functions under the
Molecular and Cellular functions category. A total of 155, 214
and 274 genes in the low, medium, and high concentrations in
vitro, and 32, 36 and 211 genes in the low, medium, and high
doses in vivo were associated with cellular growth and
proliferation. In cell cultures, this function was enriched with
annotation terms such as proliferation of cells, muscle cells,
fibroblasts, connective tissue cells, and mesenchymal cells
(Figure 9C). In the lung tissues however, cellular growth and
proliferation function was associated with annotation terms
such as proliferation of cells, tumor cells, immune cells, blood
Table 6. Top four canonical pathways affected in all three
doses in vitro.
Canonical Pathways Gene names*
Hepatic Fibrosis/
Hepatic Stellate Cell
Activation
Acta2, Ccl5, Col1a1, Col1a2, Col3a1, Ctgf, Cxcr3, Edn1,
Fas, Fgf1, Figf, Igf1, Il1r1, Il1rl1, Il4r, Lama1, Lbp, Met,
Mmp13, Myh10, Myl6b, Pdgfa, Pdgfc, Pdgfra, Pdgfrb,
Rela, Serpinb2, Smad4, Tgfb2, Tgfb3, Tnfrsf11b,
Tnfrsf1a, Vcam1, Vegfa
Aryl Hydrocarbon
Receptor Signaling
Ahr, Aldh1a1, Aldh3b1, Aldh4a1, Aldh6a1, Aldh7a1,
Aldh9a1, Ccnd1, Ccnd3, Cdkn1A, Cyp1b1, Esr1, Fas,
Fos, Gsta3, Gsta5, Gstm1, Gstm3, Gsto1, Gsto2, Gstt1,
Hsp90b1, Hspb2, Jun, Mdm2, Mgst1, Myc, Nfe2l2, Nqo2,
Rela, Tgfb2, Tgfb3, Tgm2
Superpathway of
Cholesterol
Biosynthesis
Acat2/Acat3, Dhcr7, Dhcr24, Ebp, Fdft1, Fdps, Hadhb,
Hmgcs1, Hsd17b7, Idi1, Lss, Msmo1, Mvd, Mvk, Nsdhl,
Pmvk, Sc5dl, Sqle, Tm7sf2
Glutathione-Mediated
Detoxification
Gsta3, Gsta4, Gsta5, Gstm1, Gstm3, Gsto1, Gsto2,
Gstt1, Gstt3, Gstz1, Mgst1
*. Genes associated with each of the pathways are presented.
doi: 10.1371/journal.pone.0080452.t006
cells and proliferation of mononuclear leukocytes (Figure 9D).
We then analysed the high-level function given the name
‘cancer’ that was significantly enriched in both cell cultures and
tissues under the Diseases and Disorders category. A total of
103, 163, and 220 genes in the low, medium, and high
concentrations in vitro, and 60, 40, and 159 genes in the low,
medium, and high concentrations in vivo were associated with
this function. This function was associated with terms such as
cancer, epithelial neoplasia, cell transformation, solid tumor,
and metastasis both in vivo and in vitro (Figures 9E and 9F). In
tissues, annotation terms included growth of tumour, neoplasia
of cells, carcinoma, metastasis and other related terms for this
function. Further systematic analysis of all of the genes
associated with cellular growth and proliferation and cancer
revealed that in vitro these genes primarily include transcription
factors and transcription regulators. In contrast, genes affected
in vivo were grouped primarily into two categories involved with
growth factors and inflammatory modulators in addition to other
secretory molecules. In keeping with this result we found
significant enrichment of the function ‘gene expression’ in cells
in culture, with > 200 genes in this category compared to
approximately 10 genes associated with ‘gene expression’
function in tissues (Figure 10). Our analysis clearly
demonstrates that significantly more genes are associated with
cell signalling in vivo compared to in vitro following Mitsui7
exposure. These results indicate that although most of the
genes altered in both in vivo and in vitro belong to the same
functional categories, suggesting a similar biological response
to Mitsui7, the underlying mechanisms and the outcome of
such alteration could potentially be different in the two systems
studied.
We explored the in vitro and in vivo data sets to identify
potential commonalities in the two systems that may contribute
to the same biological outcome, and thus point to the specific
relevance of this cell culture model. We conducted a detailed
analysis of the responsive genes in the top five significantly
enriched canonical pathways affected in both cells and lung
tissues. This downstream analysis was limited to the top five
Figure 8.  Top three biological networks in vitro.  The networks were generated by merging the top three networks in each of the
dose and were based on the connectivity between each gene and the molecular interaction knowledge base in IPA. Nodes are
highlighted in large bold font. Green indicates down-regulation and red indicates up-regulation.
doi: 10.1371/journal.pone.0080452.g008
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affected pathways to minimize the number of interpretations.
The top five pathways included: hepatic fibrosis/hepatic stellate
activation, AHR signalling, glutathione mediated detoxification,
superpathways of cholesterol synthesis, and LPS/IL-1
mediated inhibition of RAR function. Since hepatic fibrosis/
hepatic stellate activation and LPS/IL-1 mediated inhibition of
RAR function showed a high amount of overlap (i.e., genes
functioning in both pathways), we excluded the latter from the
analysis. Our examination of all of the genes grouped under
each of these pathways revealed that these genes are all
regulated by a common nuclear receptor, AHR, and are
associated with four major biological processes regulated by
the AHR: cell cycle regulation, xenobiotic metabolism,
inflammation, and tissue fibrosis (Figure 11). While the
common genes involved in cell cycle regulation were similarly
up-regulated in both tissues and cell cultures exposed to
Figure 9.  Comparison of biological functions and networks altered in vitro and in vivo.  Top 10 biological functions altered in
lung epithelial cells (A, C, E) and in the lung tissue (B, D, F). The spatial visualization of gene network associated with the biological
functions cellular growth and proliferation (C-D) and cancer (E-F). Grey lines connect the significantly differentially expressed genes
to the annotation terms associated with each biological function.
doi: 10.1371/journal.pone.0080452.g009
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Mitsui7, genes involved in glutathione mediated detoxification
and fibrosis were down-regulated in both systems. Although
changes in expression of genes associated with similar
functions (cell cycle, inflammation and fibrosis) were observed
across all of the concentrations, perturbation of cell cycle and
xenobiotic metabolism processes were only observed in the
low dose group in the lung tissues, and perturbations in
inflammation and fibrosis were only observed at the high dose
in vivo. These results confirm our earlier interpretation that
there was a dose dependent transition in response/toxicity in
tissues, but there was no such dose-related transition of
biological functions (by IPA) in cell cultures.
In addition to the analysis described above, we also
examined our gene lists for markers of inflammation, oxidative
stress, and tissue damage (fibrosis) since these effects are the
well-characterized endpoints for both tissues and cells in
culture following exposure to MWCNT. More than 100 genes
that are known to be associated with each of these
characteristic markers of MWCNT were used to build a heat-
map (Figure 12) to visualize the similarities and differences
between the test systems. Only the genes that showed
significant expression changes in either cell cultures and/or the
lung tissues treated with Mitsui7 (in at least one exposure
group) are shown in color (red up-regulated; green down-
regulated; grey no change). Although the total number of genes
altered in each of these pathways was somewhat similar
between the two models, differentially expressed genes in vitro
were associated mainly with positive regulation of oxidative
stress and fibrosis. In the lung tissues, perturbed genes were
associated predominantly with pro-inflammation. Although the
lung tissue showed significant alteration in the expression of a
number of genes in the fibrosis category, expression profile
was indicative of negative regulation of fibrosis. ROS
generation and oxidative stress have been proposed to be the
primary mode of action of many ENM [1], where a balance
between enzyme-mediated ROS generation and ROS
detoxification by antioxidant enzymes and the level of
intracellular antioxidants such as glutathione regulate
intracellular ROS-mediated stress. Up-regulation of antioxidant
enzymes including SOD, catalase, GPx and thioredoxin is
considered as indication of adaptation to oxidative stress [62].
In the lung tissue, oxidative stress-associated genes, such as
Sod2, Ucp2, and Ucp3, were up-regulated. SOD2 is localized
to mitochondria and transforms superoxide radicals into
Figure 10.  The total number of genes perturbed in the categories of gene expression and cellular signalling
functions.  Green: low dose (12.5 µg in vitro, 18 µg in vivo), blue: medium dose (25 µg in vitro, 54 µg in vivo), and red: high dose
(100 µg in vitro, 162 µg in vivo).
doi: 10.1371/journal.pone.0080452.g010
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hydrogen peroxide that in turn are converted to water and
oxygen by catalase or glutathione peroxidase. Uncoupling
protein 2 and 3 (UCP-2, -3) are the major components of the
electron transport chain. Ucp genes act to uncouple the proton
gradient in the inner mitochondrial membrane, allowing protons
to re-enter the mitochondrial matrix thereby regulating build-up
of ROS in cells [63,64]. Similar mitochondrial respiration
leakage and up-regulation of mitochondria-specific antioxidants
such as SOD2 has been reported in mice intratracheally
instilled with SWCNT [65]. The results suggest that the
oxidative stress observed in vivo was potentially due to
mitochondrial respiration leakage. In contrast, Sod1 and Sod3
were down-regulated in vitro and Hmox1, Sqstm1, Srxn1,
Txnip, Txnrd1, Txnrd3 were up-regulated. These differences
suggest that broadly different mechanisms are driving the
oxidative stress in vitro. However, it is important to note that the
observed differences could also be due to the different time
points investigated in the two systems. Further work
considering early time points is warranted to rectify these
conclusions.
A similar contradiction in the underlying mechanisms
involved in the function ‘fibrosis’ was also observed in the two
systems. Matrix metalloproteinases (MMPs) were up-regulated
in cells in culture, whereas, the expression of inhibitors of
metalloproteinases (TIMP) was increased in the lung tissue. A
profound increase in the expression of several acute phase
stress genes (Saa, Cxcls and Ccls), chemokines, and
cytokines was observed in the lung tissue, mainly reflecting
chemotaxis and infiltration of inflammatory cells into the lungs.
However, in contrast, increased expression of inflammatory
genes was associated with epithelial activation (e.g., Ccl5,
Ptgs2) in vitro. Overall, these results suggest different
mechanisms, varying degrees of severity in response and
potentially different biological outcomes to Mitsui7 exposure in
epithelial cells in culture and lung tissue.
In order to understand if the observed discrepancies
between the models were due to basal level differences in the
expression of genes in the two systems studied, we compared
gene expression profiles of vehicle treated controls of lung
epithelial cells and mouse lung tissues. We found that 60% of
the genes had comparable expression levels (15,972 of 26,409
analyzed), which included genes implicated in the inflammatory
and acute phase responses. Thus, differences in expression
were observed for 40% of the genes (Table S4) and these
genes were mainly associated with biological processes such
as Cellular growth and proliferation, Cancer, Cell death and
survival, Cell cycle and Cellular movement in lung epithelial
cells, which mainly reflect the consequences of cellular
immortalization processes. These results imply that altered
basal expression levels in thousands of genes involved in
Growth and Proliferation, Cell cycle and other important
biological functions may play a critical role in how cells in
culture respond to external stimuli such as nanomaterials. The
high basal levels of expression of several growth and survival
Figure 11.  Differentially expressed genes associated with five top canonical pathways derived from IPA analysis.  Genes
are categorized into four major functions (cell cycle regulation-orange, xenobiotic metabolism-green, inflammation-violet, and
tissue fibrosis-blue). All genes in both models are regulated by a common transcription factor, AHR. Genes highlighted with green
indicate down-regulation and genes highlighted with red indicate up-regulation. The transcription factor AHR is down-regulated in
cells, suggesting negative regulation of the downstream functions in cells.
doi: 10.1371/journal.pone.0080452.g011
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Figure 12.  Gene heatmap comparing differentially expressed genes in the categories of fibrosis, inflammation and
oxidative stress.  Red represents up-regulation, green represents down-regulation and grey represents no change in the
expression.
doi: 10.1371/journal.pone.0080452.g012
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factors may provide protection against cellular injury caused by
exposure to nanomaterials. This hypothesis was supported by
the observed lack of response in cells treated with very low
concentrations of MWCNT (described below, Table 7 and 8). In
contrast, changes in the expression of important acute phase
and inflammatory genes were observed in lung tissues even at
the very low doses. Our results suggest that data from single
cell models must be interpreted with caution.
Table 7. RT-qPCR validation of genes in lung tissue.
 Genes 2μg   6 μg  18 μg 54 μg 162 μg
 
PCR
array
PCR
array
PCR
array Microarray  
PCR
array Microarray  
PCR
array Microarray
Saa3 5.5 - - 9.9 215.8 12.3 348.7 45.6
Cxcl5 - - 66.9 - 188.8 5.3 81.5 4.1
Cxcl1 - - 8.0 2.3 20.5 3.9 22.1 4.7
Ccl2 - 3.6 14.5 3.5 - 5.0 21.9 3.9
Ccl7 - 8.0 - 5.5 65.9 6.9 20.2 4.3
Il6 - 2.0 - 2.8 - 4.0 16.1 6.5
Timp1 - 3.0 - 7.7 - 9.7 13.1 11.7
Ccl11 - 4.4 - 3.0 15.6 5.2 5.3 3.4
Saa1 - - - 3.8 - 7.0 5.0 12.3
Ccl17 3.1 5.2 7.8 3.5 7.5 3.4 4.9 2.8
Ccl3 1.9 - 3.7 1.9 - - 4.6 2.4
Lox - - 2.1 - 1.8 - 3.8 2.4
Myc 1.5 - 1.9 - 2.0 - 3.0 1.9
Cd14 - - 2.4 - 2.7 - 2.9 2.0
Ccl19 - - - - - - 2.7 2.5
Il33 - - - 2.8 3.8 - 2.6 -
Cxcl10 - 2.4 - 4.5 13.8 6.0 2.5 -
Thbs1 - - 1.9 - - 2.9 2.4 2.1
Ctgf - - - - - - 2.4 2.0
Gclc - 1.3 2.1 - - - 2.2 1.8
Fth1 - - - - - - 2.0 2.3
Ptgs1 - - - - - - 1.9 2.8
Nox4 - - - -1.8 -3.6 - -1.7 -
Ltb - -1.5 - - - - -2.2 -2.1
Serpinh1 - - 1.8 - - - -2.6 -2.2
Tnfsf10 - - - - -2.3 - -4.5 -2.8
Timp3 - -1.5 -1.7 - -2.0 - - 2.3
Sod2 - - - - - - - 1.8
Ucp2 - - -1.6 - -2.0 - - 2.2
Cxcl13 - - - - 5.3 - - 3.8
Prdx6 - -1.8 -2.4 -1.5 -3.0 - - 1.5
Ucp3 - -1.7 -2.5 - -2.0 - - 2.2
Edn1 - -1.7 - - -2.5 - - 1.9
Itga3 - - - - -1.7 - - 2.1
C3 - 1.8 - 2.3 2.8 - - -
Only significantly differentially expressed genes are shown (FDR P<0.05, fold
change >1.5 in either direction). Data were normalized using Hprt, Gapdh, and
Actb as reference genes.
doi: 10.1371/journal.pone.0080452.t007
Validation of microarray results by RT-qPCR
We validated 42 genes altered in cell cultures and 42 genes
in tissues (84 in total) categorised under three main established
markers of MWCNT-induced effects: oxidative stress,
inflammation, and fibrosis. A complete list of genes validated
by RT-qPCR is provided in Table S5. Because the exposures
used in the DNA microarray analysis are considered to be high
compared to the expected exposure levels in the environment,
we included a range of lower (lower than 12.5 μg/ml in in vitro
and lower than 18 μg/mouse in vivo) exposure levels for RT-
qPCR validation. The final validation by RT-qPCR included
0.0125, 0.125, 1.25, 12.5, 25 and 100 µg/ml in FE1 cells, and
2, 6, 18, 54, 162 µg/mouse in vivo. The RT-qPCR results were
broadly consistent with the microarray results (Tables 7 and 8).
Interestingly, in cell cultures, no significant changes were
observed, with the exception of moderate down-regulation of
Mmp3 and up-regulation of Cx3cl1 at the lowest concentration
(0.0125 µg/ml) tested, (we note that the direction of change for
Cx3cl1 was reversed at the higher concentrations). In order to
confirm that lack of response in FE1 cells following low
concentration exposures was not due to the analysis of only a
subset of genes associated with a few biological effects, global
analysis of gene expression analysis was performed (as
described above) on the lower concentration (0.0125, 0.125,
1.25 µg/ml) groups. The microarray analysis (data not shown)
confirmed the subtle response observed by RT-qPCR. In
contrast, in the lung tissues, several genes (Saa3, C3, Cxcl10,
Myc, Ccl3, Ccl17, Ccl11, Timp1, IL6, Ccl7, Ccl2 and Cxcl5)
involved in acute phase and inflammation were significantly up-
regulated even at the lowest concentrations tested (2 µg/
mouse). The data suggest that the lung tissue is generally
more sensitive to Mitsui7 exposure than the FE1 lung epithelial
cells and that these genes can potentially be used as sensitive
markers of exposure to Mitsui7 and like particles.
Perspectives
Despite the urgent need for rapid in vitro assays that are
predictive of in vivo toxicity for ENM testing, few in vitro
validation exercises have been conducted to comprehensively
characterize mechanistic similarities and differences for ENM-
exposed cells in culture compared to tissues from live model
organisms exposed to ENM. Existing publications on this topic
have been limited to a small selection of biological endpoints
that include inflammation, oxidative stress, and tissue damage
(reviewed in 9,66-68). In these existing studies, the in vivo lung
toxicity assays applied have generally consisted of analysis of
BAL fluid for markers of inflammation (infiltration of
inflammatory cells, increased production of cytokines and
chemokines), oxidative stress (oxidative stress markers, DNA
damage), and cytotoxicity (LDH and alkaline phosphatase).
These measurements are then analyzed in parallel in cells
exposed in vitro to the same substance. For example, Wang et
al. [15], measured markers of fibrosis in lung tissues and in
different lung cell culture models and found good agreement
between the profibrogenic responses in vitro and in vivo [15]. In
another study, Horie et al. [69] measured levels of hydroperoxy
octadecadienoate (tHODE), an indicator of oxidative stress, in
rat lungs exposed to nickel nanoparticles and in cells exposed
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in Petri culture dishes. They showed comparable increases in
tHODE 24 hours after the exposure to particles in vivo and in
vitro [69]. However, although similar perturbations were
described in vitro and in vivo in the above studies, the
magnitude of response between the lung tissue and cells in
culture in the above studies was different. These differences in
the magnitude of response may occur because of difficulties in
matching the predicted particle-exposed lung surface area to
the surface area of Petri dishes in which the cells are
incubated. Moreover, in vivo studies evaluated toxicity in
complex multi-cellular tissues; whereas, in vitro studies
primarily focus on understanding the response of a single cell
type isolated from a specific organ.
Table 8. RT-qPCR validation of genes in cells.
 Genes 0.00125 0.125 1.25 12.5 25.0 100.0
 PCR array PCR array PCR array PCR array Microarray PCR array Microarray PCR array Microarray
Mmp13 - - 1.6 15.0 9.7 18.2 12.7 27.6 10.6
Serpine1 - - - 7.3 2.9 5.9 3.9 10.1 5.0
Ccl5 - - - 2.3 3.0 4.3 2.7 8.0 3.4
Ctgf - - - 3.9 3.0 5.4 4.3 7.7 4.6
Mmp3 - - 2.9 33.1 3.5 5.3 3.9 7.0 3.0
Sqstm1 - - - 4.0 1.8 4.1 2.0 6.2 2.6
Grem1 - - 1.7 2.4 2.5 3.4 2.4 5.5 2.5
Tgif1 - - - 5.5 2.0 4.4 2.3 5.0 2.5
Hmox1 - - - 2.7 - 3.1 2.1 4.7 2.5
Myc - - - 4.1 1.8 3.0 2.8 4.6 2.6
Tnfrsf11b - - - -1.7 2.1 3.0 2.2 4.3 2.0
Jun - - - - 2.3 2.8 2.8 3.7 3.0
Ptgs2 - - - 5.4 2.5 2.6 2.9 3.7 2.6
Spp1 - - - 3.3 2.0 3.2 - 3.5 -
Fos - - -1.5 -7.8 - 2.7 - 3.1 1.8
Vegfa - - - - - 2.2 - 2.7 1.6
Edn1 - - - 1.5 2.2 2.6 2.5 2.7 2.2
Txnip - - - 2.5 - 2.0 - 2.6 1.7
Txnrd1 - - - 3.1 1.7 2.2 1.9 2.5 2.1
Srxn1 - - - - - 1.7 1.5 2.1 1.5
Txnrd3 - - - 2.9 - 2.0 1.7 2.1 1.8
Cebpb - - - - - - - 1.8 1.6
Cygb - - - 1.7 - 1.6 -1.6 1.8 -1.6
Cx3cl1 - - - - -2.4 -1.8 -2.4 -1.5 -2.3
Plat - - - - -1.6 -1.8 -1.6 -1.5 -1.5
C3 - - - -2.8 -2.0 -1.7 -2.1 -1.7 -2.2
Il1r1 - - - -2.2 -1.7 -2.1 -1.7 -1.9 -2.0
Cxcl12 - - - -5.6 - -1.9 -2.3 -2.1 -3.0
Col3a1 - - - -8.6 -1.8 -2.1 -2.4 -2.3 -3.3
Il18 - - - -9.6 -1.8 -2.5 -2.0 -2.4 -2.4
Smad6 - - - -3.6 -1.8 -2.4 -2.1 -2.5 -2.7
Tgfb3 - - - -5.0 - -2.4 -1.9 -2.5 -2.7
Il15 - - - -3.0 -1.5 -2.6 -1.5 -2.7 -1.5
Idh1 - - - -4.9 - -2.3 -1.9 -3.0 -2.0
Dcn - - - -4.9 - -2.7 -3.4 -3.1 -4.7
Aox1 - - - -4.5 -2.4 -4.1 -3.2 -3.7 -3.2
Tgfb2 - - - -7.9 -1.7 -3.5 -2.3 -4.6 -3.4
Il33 - - - -67.3 -3.6 - -4.4 -13.0 -6.8
Col1a2 - - - -5.6 -1.7 - -2.4 - -2.8
Gpx7 - - - -2.3 - - - - -1.8
Pdgfa - - - -1.7 -1.5 - - - -1.5
Cxcr3 - - - 1.6 1.5 1.9 - - -
Only significantly differentially expressed genes are shown (FDR P<0.05, fold change >1.5 in either direction). Data were normalized using Gapdh and Actb as reference
genes.
doi: 10.1371/journal.pone.0080452.t008
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In the present study, we exposed mice via instillation and
incubated mouse lung epithelial cells in culture dishes to three
different doses of Mitsui7. Our in vivo to in vitro dose
comparison was based on the total lung surface area and the
total surface area of the Petri dish in which cells were exposed
(Table 2). Unlike previous studies, we analyzed the global gene
expression response to Mitsui7 in lung tissue and cells using
comprehensive and high-content DNA microarrays to globally
characterize potential mechanistic differences in response.
Three major concepts emerged from this analysis: (1) the
primary toxic response in vivo was an early acute phase and
inflammation dose-response which was not activated in vitro;
(2) the in vitro model is less responsive than the in vivo at lower
doses and does not show a dose-response pattern in the
induction of toxicity pathways at increasingly higher
concentrations; and (3) both models respond by activating
similar core cellular functions (oxidative stress and fibrosis) at
the pathway level, however, regulation of most individual
genes, the underlying mechanisms and consequent nature of
the biological response are different. We suggest that careful
consideration should be given to the in vitro concentrations
selected, the types of cells used, and the endpoints studied
when deriving regulatory decisions for ENM such as Mitsui7.
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